Benralizumab for Eosinophil-Related Cutaneous Adverse Events of Anticancer Therapy: A Phase II Trial
- DOI
- 10.1158/1078-0432.ccr-25-2764
- Published
- 2026-05-05
- Container
- Clinical Cancer Research
- Publisher
- American Association for Cancer Research (AACR)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1158/1078-0432.ccr-25-2764,
title = {Benralizumab for Eosinophil-Related Cutaneous Adverse Events of Anticancer Therapy: A Phase II Trial},
author = {Mario E. Lacouture and Alexander Pan and Tara Maier and Anna Chen and George Dranitsaris and Neil J. Shah and Chau Dang and Devika Gajria and Allison Gordon and Neil Iyengar and Pedram Razavi and Mark Robson and Ezra Rosen and Serena Wong and Ucalene Harris and Kwami Ketosugbo and Cindy Bravo and Manu Jain and Alina Markova},
year = {2026},
journal = {Clinical Cancer Research},
doi = {10.1158/1078-0432.ccr-25-2764},
url = {https://doi.org/10.1158/1078-0432.ccr-25-2764}
}RIS
TY - JOUR TI - Benralizumab for Eosinophil-Related Cutaneous Adverse Events of Anticancer Therapy: A Phase II Trial AU - Mario E. Lacouture AU - Alexander Pan AU - Tara Maier AU - Anna Chen AU - George Dranitsaris AU - Neil J. Shah AU - Chau Dang AU - Devika Gajria AU - Allison Gordon AU - Neil Iyengar AU - Pedram Razavi AU - Mark Robson AU - Ezra Rosen AU - Serena Wong AU - Ucalene Harris AU - Kwami Ketosugbo AU - Cindy Bravo AU - Manu Jain AU - Alina Markova PY - 2026 JO - Clinical Cancer Research DO - 10.1158/1078-0432.ccr-25-2764 UR - https://doi.org/10.1158/1078-0432.ccr-25-2764 ER -
APA
Lacouture, M. E., Pan, A., Maier, T., Chen, A., Dranitsaris, G., Shah, N. J., Dang, C., Gajria, D., Gordon, A., Iyengar, N., Razavi, P., Robson, M., Rosen, E., Wong, S., Harris, U., Ketosugbo, K., Bravo, C., Jain, M., & Markova, A. (2026). Benralizumab for Eosinophil-Related Cutaneous Adverse Events of Anticancer Therapy: A Phase II Trial. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-25-2764
Source records
- crossref · retrieved 2026-09-26T20:52:24.806Z